Who Owns Caris Life Sciences Stock?
NASDAQ: CAIHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 56.56%
- Institutions (% of float)
- 110.45%
- Held by insiders
- 48.79%
- Institutional holders
- 348
- Institutions 51.2%
- Insiders 48.8%
- Public and other 0.0%
Who owns Caris Life Sciences stock?
Institutional investors own about 56.6% of Caris Life Sciences's shares, spread across 348 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 48.79% of CAI.
The largest institutional holders are FMR, LLC (10.94%), J. H. Whitney Equity Partners VI, LLC (3.98%) and Coatue Management LLC (3.47%). Together, the top 10 institutions control 34.1% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their CAI positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CAI
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 30.92M | 10.94% | +0.5% |
| J. H. Whitney Equity Partners VI, LLC | 11.26M | 3.98% | -38.3% |
| Coatue Management LLC | 9.82M | 3.47% | 0.0% |
| Braidwell LP | 8.26M | 2.92% | +3.1% |
| Sixth Street Partners Management Company, L.P. | 7.33M | 2.59% | -49.1% |
| PointState Capital LP | 6.83M | 2.42% | -7.2% |
| JPMORGAN CHASE & CO | 6.56M | 2.32% | +89.5% |
| Blackrock Inc. | 5.54M | 1.96% | +14.0% |
| T. Rowe Price Investment Management, Inc. | 5.08M | 1.80% | -9.1% |
| Vanguard Portfolio Management LLC | 4.84M | 1.71% | +28.9% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CAI
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Contrafund | 4.07M | 1.44% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 4.05M | 1.43% |
| JPMorgan Trust II-JPMorgan Mid Cap Growth Fund | 3.32M | 1.18% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.92M | 1.03% |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | 2.70M | 0.96% |
| Fidelity Select Portfolios-Select Health Care Portfolio | 1.89M | 0.67% |
| Variable Insurance Products Fund III-VIP Mid Cap Portfolio | 1.79M | 0.63% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.69M | 0.60% |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 1.68M | 0.60% |
| Variable Insurance Products Fund II-VIP Contrafund Portfolio | 1.40M | 0.50% |
Frequently asked questions
Who is the largest shareholder of Caris Life Sciences?
FMR, LLC is the largest institutional shareholder of CAI, owning 10.94% of shares outstanding (30.92M shares) as of its latest 13F filing.
What percentage of Caris Life Sciences is owned by institutions?
Institutions own about 56.6% of CAI shares and 110.4% of the public float.
How much of Caris Life Sciences do insiders own?
Insiders, such as officers and directors, own about 48.79% of CAI shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.